MYOCARDIAL CYTOPROTECTOR TRIMETAZIDINE MB-PREPARAT, INCREASES THE EFFECTIVENESS OF TREATMENT OF CHRONIC HEART FAILURE AND CORONARY HEART DISEASE

Abstract

The results of numerous foreign and russian researches indicate that administration of trimetazidine MB, including its russian generic drug Deprenorm® MV, in the treatment of patients with ischemic heart disease, including those with concomitant chronic heart failure, is a real opportunity to improve the effectiveness of treatment of such patients.

Keywords

• ischemic heart disease
• chronic heart failure
• effective therapy
• trimetazidine
• deprenorm® mv 70 mg